TrialBreast cancer research and treatment2016

Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622.

Anne F Schott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.